Suchergebnisse - "Hoster, Eva"

PubPharm (177)

1

Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma : results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group

enthalten in: Annals of hematology | 2024

von Scheubeck, G. | Hoffmann, M. | Jurinovic, V. | +13

2

Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma : Results From the European Mantle Cell Lymphoma Elderly Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Hoster, E. | Delfau-Larue, M. | Macintyre, E. | +15

3

Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma : A Prospective Analysis of the Phase III GALLIUM Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Pott, C. | Jurinovic, V. | Trotman, J. | +19

4

The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma - a randomized, open-label phase III trial of the European mantle cell lymphoma network

enthalten in: ResearchSquare.com | 2023

von Fischer, L. | Jiang, L. | Dürig, J. | +28

5

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL

enthalten in: Blood advances | 2023

von Blumenberg, V. | Busch, G. | Baumann, S. | +24

6

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms

enthalten in: Leukemia | 2023

von Kalmbach, S. | Grau, M. | Zapukhlyak, M. | +26

7

The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis

enthalten in: Annals of hematology | 2023

von Fischer, L. | Jiang, L. | Bittenbring, J. | +15

8

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

enthalten in: Leukemia | 2023

von Scheubeck, G. | Jiang, L. | Hermine, O. | +11

9

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma : Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

enthalten in: HemaSphere | 2023

von Bücklein, V. | Perez, A. | Rejeski, K. | +24

ErratumIn: Hemasphere. 2023 Oct 31;7(11):e982. - PMID 37920708

10

Long-term outcome in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation

enthalten in: European journal of haematology | 2023

von Metzner, B. | Müller, T. | Casper, J. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]